首页> 中文期刊> 《世界中医药》 >清肝解毒止咳方治疗病毒感染后慢性咳嗽的临床研究

清肝解毒止咳方治疗病毒感染后慢性咳嗽的临床研究

         

摘要

Objective:To investigate the curative effect of QingGan JieDu ZhiKe Prescription from Dezhou Hospital of Traditional Chi -nese Medicine on chronic cough after virus infection .Methods:Take the method of random , contrast, double blind for research .Divid-ed patients that accorded with our research standards into treatment group and control group .Patients in the treatment group were treated by QingGan JieDu ZhiKe Prescription , meanwhile the control group was treated by budesonide and formoterol fumarate powder for inhala -tion.Differences on curing time , the improvement of symptom , living quality and the recurrence rate were compared two weeks after treatment.Results:Through comparison, treatment group took less time to be cured compared to the control group (P<0.05).After two weeks of treatment, living quality in the treatment group was better improved than that in the control group (P<0.05).Two weeks after the treatment was finished , recurrence rate in the treatment group was lower than that in the control group ( P<0.05 ) .Conclu-sion:QingGan JieDu ZhiKe Prescription has significant advantage on course of treatment , improvement of living quality and recurrence rate control on chronic cough after virus infection .It is worth using in clinical practice .%目的:研究本院协定方-清肝解毒止咳方治疗病毒感染后慢性咳嗽的临床疗效。方法:采用随机对照双盲的方法,对符合研究标准的慢性咳嗽患者分为治疗组和对照组,治疗组给予以清肝解毒止咳方为基础方的中药治疗,对照组采用福莫特罗/布地奈德粉吸入剂治疗。比较两组间疗效、生活质量改善以及停药2周后咳嗽复发情况的差异性。结果:通过比较发现,在痊愈患者中,治疗组时间短于对照组(P<0.05);治疗2周后,生活质量改善方面治疗组明显优于对照组(P<0.05);停药2周后,治疗组复发率明显低于对照组( P<0.05)。结论:对于病毒感染后慢性咳嗽,以清肝解毒止咳方为基础方的协定处方在缩短病程、改善患者生活质量和控制复发率上有明显优势,值得临床推广运用。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号